BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31779209)

  • 1. Evaluation of the Reactivity and Receptor Competition of HLA-G Isoforms toward Available Antibodies: Implications of Structural Characteristics of HLA-G Isoforms.
    Furukawa A; Meguro M; Yamazaki R; Watanabe H; Takahashi A; Kuroki K; Maenaka K
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and Functional Basis for LILRB Immune Checkpoint Receptor Recognition of HLA-G Isoforms.
    Kuroki K; Matsubara H; Kanda R; Miyashita N; Shiroishi M; Fukunaga Y; Kamishikiryo J; Fukunaga A; Fukuhara H; Hirose K; Hunt JS; Sugita Y; Kita S; Ose T; Maenaka K
    J Immunol; 2019 Dec; 203(12):3386-3394. PubMed ID: 31694909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting Edge: Class II-like Structural Features and Strong Receptor Binding of the Nonclassical HLA-G2 Isoform Homodimer.
    Kuroki K; Mio K; Takahashi A; Matsubara H; Kasai Y; Manaka S; Kikkawa M; Hamada D; Sato C; Maenaka K
    J Immunol; 2017 May; 198(9):3399-3403. PubMed ID: 28348268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors.
    HoWangYin KY; Loustau M; Wu J; Alegre E; Daouya M; Caumartin J; Sousa S; Horuzsko A; Carosella ED; LeMaoult J
    Cell Mol Life Sci; 2012 Dec; 69(23):4041-9. PubMed ID: 22802125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessment of HLA-G isoform specificity of MEM-G/9 and 4H84 monoclonal antibodies.
    Zhao L; Teklemariam T; Hantash BM
    Tissue Antigens; 2012 Sep; 80(3):231-8. PubMed ID: 22738368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunosuppressive effect of domain-deleted dimer of HLA-G2 isoform in collagen-induced arthritis mice.
    Takahashi A; Kuroki K; Okabe Y; Kasai Y; Matsumoto N; Yamada C; Takai T; Ose T; Kon S; Matsuda T; Maenaka K
    Hum Immunol; 2016 Sep; 77(9):754-9. PubMed ID: 26805457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A soluble recombinant form of human leucocyte antigen-G 6 (srHLA-G6).
    Pelá FP; Rustiguel JK; Rodrigues LC; Mendonça JN; Andrade CDC; Lopes NP; Rosa JC; Nonato MC; Favier B; Donadi EA; Dias-Baruffi M
    Biochem Biophys Res Commun; 2017 May; 487(1):28-33. PubMed ID: 28365155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer.
    Shiroishi M; Kuroki K; Ose T; Rasubala L; Shiratori I; Arase H; Tsumoto K; Kumagai I; Kohda D; Maenaka K
    J Biol Chem; 2006 Apr; 281(15):10439-47. PubMed ID: 16455647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Modeling and Molecular Dynamics of the Immune Checkpoint Molecule HLA-G.
    Arns T; Antunes DA; Abella JR; Rigo MM; Kavraki LE; Giuliatti S; Donadi EA
    Front Immunol; 2020; 11():575076. PubMed ID: 33240264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules.
    Menier C; Saez B; Horejsi V; Martinozzi S; Krawice-Radanne I; Bruel S; Le Danff C; Reboul M; Hilgert I; Rabreau M; Larrad ML; Pla M; Carosella ED; Rouas-Freiss N
    Hum Immunol; 2003 Mar; 64(3):315-26. PubMed ID: 12590976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex.
    Wang Q; Song H; Cheng H; Qi J; Nam G; Tan S; Wang J; Fang M; Shi Y; Tian Z; Cao X; An Z; Yan J; Gao GF
    Cell Mol Immunol; 2020 Sep; 17(9):966-975. PubMed ID: 31273318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunosuppressive molecule HLA-G and its clinical implications.
    González A; Rebmann V; LeMaoult J; Horn PA; Carosella ED; Alegre E
    Crit Rev Clin Lab Sci; 2012; 49(3):63-84. PubMed ID: 22537084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
    Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
    Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules.
    Poláková K; Bennink JR; Yewdell JW; Bystrická M; Bandzuchová E; Russ G
    Hum Immunol; 2003 Feb; 64(2):256-64. PubMed ID: 12559628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
    Attia JVD; Dessens CE; van de Water R; Houvast RD; Kuppen PJK; Krijgsman D
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA Class I protein expression in the human placenta.
    Blaschitz A; Hutter H; Dohr G
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-G1 and HLA-G5 isoforms have an additive effect on NK cytolysis.
    Zhang WQ; Xu DP; Liu D; Li YY; Ruan YY; Lin A; Yan WH
    Hum Immunol; 2014 Feb; 75(2):182-9. PubMed ID: 24269702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
    Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
    Am J Reprod Immunol; 1998 Sep; 40(3):136-44. PubMed ID: 9764357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.